The combination therapy of hypertension to prevent cardiovascular events (COPE) trial: rationale and design.
Ogihara T, Matsuzaki M, Matsuoka H, Shimamoto K, Shimada K, Rakugi H, Umemoto S, Kamiya A, Suzuki N, Kumagai H, Ohashi Y, Takishita S, Abe K, Saruta T; COPE Trial Group.
Ogihara T, et al.
Hypertens Res. 2005 Apr;28(4):331-8. doi: 10.1291/hypres.28.331.
Hypertens Res. 2005.
PMID: 16138563
Review.